Skip to Content
Shadow

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Agile President and CEO Appointed as an Officer of the Dean's Advisory Board, Drexel University, Lebow College of Business
Agile President and CEO Appointed as an Officer of the Dean's Advisory Board, Drexel University, Lebow College of Business The Dean’s Advisory Board elected five new members and three new officers at its fall meeting – its first held in Gerri C. LeBow Hall....
Toggle Summary Agile Therapeutics Commercial Head Presents at 7th Annual Digital Pharma East - Working With Patient Advocacy Groups to Develop an Integrated Unbranded Education and Adherence Program: Experience in Contraception in Young Women
Toggle Summary Data on Agile Therapeutics' Low-Dose Contraceptive Patch (AG200-15) Presented at American College of Obstetricians and Gynecologists' (ACOG) Annual Clinical Meeting
Toggle Summary Data on Agile Therapeutics Low-Dose Contraceptive Patch (AG200-15) Presented at the First Global Conference on Contraception, Reproduction and Sexual Health Organized by the European Society of Contraception and Reproductive Health (ESCRH)
Toggle Summary Agile Therapeutics President and CEO appointed to Board of BioNJ
Toggle Summary Agile Therapeutics Chief Medical Officer, Marie Foegh, MD, Named One of New Jersey's Best 50 Women in Business by NJBiz
Toggle Summary Agile Therapeutics Closes $15 Million Financing Agreement with Oxford Finance
Toggle Summary Agile Therapeutics to Present at Elsevier Business Intelligence's Therapeutic Area Partnerships
Toggle Summary Agile Therapeutics Commercial Head Named Bronze Stevie Winner in the 2012 Stevie® Awards for Women in Business
Toggle Summary Phase III Data Show Greater Compliance Across Demographic Groups With Agile Therapeutics' Contraceptive Patch Compared to an Oral Contraceptive
Shadow